Licensed Practical Nurse in Portsmouth, NH Accepting Medicare

4 Licensed Practical Nurse nurses found. Showing 1 - 4

Diane Theresa Champlin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1039 Islington St, Suite 16, Portsmouth, NH 03801 Phone: 603-431-0505    Fax: 603-431-2228

Mary Rose Cieslik, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1039 Islington St, Suite 16, Portsmouth, NH 03801 Phone: 603-431-0505    Fax: 603-431-2228

Tammy J Fisher, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1039 Islington St, Suite 16, Portsmouth, NH 03801 Phone: 603-431-0505    Fax: 603-431-2228

Mrs. Pamela Ann Turner, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1039 Islington St, Suite 16, Portsmouth, NH 03801 Phone: 603-431-0505    Fax: 603-431-2228

News Archive

Accellent to sell Pittsburgh facility to Perryman

Accellent Inc., a wholly-owned subsidiary of Accellent Holdings Corp., has entered into an agreement to sell its facility located just outside of Pittsburgh in Houston, Pennsylvania to The Perryman Company, also headquartered in Houston, Pennsylvania. Substantially all of the Facility's employees will become employees of Perryman effective upon completion of the sale, which is expected to be completed during the second quarter of 2012.

BioCancell's Phase I/IIa clinical trial of BC-819 shows positive result for pancreatic cancer

BioCancell, a developer of anti-cancer drugs, announced success in attaining the goals of its Phase I/IIa clinical trial of BC-819 as a treatment for pancreatic cancer, which demonstrated an excellent safety profile and preliminary efficacy.

Reminder letters for bowel scope screening could boost more participation

JOGGING the memory with a reminder letter to those who don't respond to their bowel scope screening invitation could mean more people would take the test, according to a Cancer Research UK-funded study published in the British Journal of Cancer today.

Top citations for scientific paper on Inovio's SynCon DNA vaccines and ID DNA delivery technology

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a scientific paper demonstrating strong and protective immune responses from candidate SynCon™ DNA vaccines in preclinical studies using Inovio's intradermal (ID) DNA delivery technology was one of the top cited scientific articles in the past three years in the journal Vaccine.

Read more Medical News

› Verified 5 days ago